| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net sales | 99,369 | 105,119 | 114,579 | 106,284 |
| Cost of product (excluding amortization) | 25,293 | 30,957 | 32,677 | 28,465 |
| Amortization of patented formulations | 2,416 | 2,705 | 2,704 | 2,184 |
| Total cost of sales | 27,709 | 33,662 | 35,381 | 30,649 |
| Gross profit | 71,660 | 71,457 | 79,198 | 75,635 |
| Selling, general, and administrative | 65,951 | 65,107 | 64,110 | 65,909 |
| Amortization of other intangible assets | 10,820 | 10,854 | 10,905 | 10,930 |
| Total operating expenses | 76,771 | 75,961 | 75,015 | 76,839 |
| Operating (gain) income | -5,111 | -4,504 | 4,183 | -1,204 |
| Interest expense | 7,132 | 7,551 | 7,691 | 12,375 |
| Interest income | 2,702 | 2,659 | 2,690 | 3,527 |
| Tax receivable agreement liability adjustment | NaN | 2,666 | 9,452 | NaN |
| Other expense (income), net | -142 | 37 | 66 | 987 |
| Total other (income) expense, net | NaN | NaN | 9,518 | NaN |
| (loss) income before provision for income taxes | -9,683 | -6,693 | 8,700 | -9,065 |
| Income tax (benefit) provision | -4,396 | 6,409 | -2,427 | -1,323 |
| Net (loss) income | -5,287 | -13,102 | 11,127 | -7,742 |
| Unrealized gain on derivatives, net of income tax effect | 139 | 151 | 139 | 121 |
| Total other comprehensive income (loss) | NaN | NaN | NaN | 121 |
| Total other comprehensive income | 139 | 151 | 139 | NaN |
| Comprehensive (loss) income | -5,148 | -12,951 | 11,266 | -7,621 |
| Basic EPS | -0.01 | -0.019 | 0.02 | -0.01 |
| Diluted EPS | -0.01 | -0.019 | 0.02 | -0.01 |
| Basic Average Shares | 669,942,446 | 668,131,083 | 667,066,071 | 665,953,788 |
| Diluted Average Shares | 669,942,446 | 664,564,133 | 668,857,769 | 665,953,788 |
OLAPLEX HOLDINGS, INC. (OLPX)
OLAPLEX HOLDINGS, INC. (OLPX)